Mid-Afternoon Market Update: NASDAQ Rises Over 100 Points; Amneal Pharmaceuticals Shares Surge On Upbeat Results

Toward the end of trading Monday, the Dow traded down 0.11% to 24305.58 while the NASDAQ rose 1.17% to 9228. The S&P also rose, gaining 0.27% to 2,937.69.

The U.S. is the new epicenter of the coronavirus pandemic with the highest number of cases and deaths around the world. U.S. reported a total of 1,329,790 coronavirus cases with around 79,520 deaths. Spain confirmed a total of over 224,350 coronavirus cases with 26,621 deaths, while Russia reported a total of at least 221,340 confirmed cases and 2,009 deaths. In total, there were at least 4,122,170 cases of COVID-19 worldwide with over 283,000 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Health care shares climbed by 1.5% on Monday. Meanwhile, top gainers in the sector included MyoKardia, Inc. MYOK, up 64%, and Cytokinetics, Incorporated CYTK, up 34%.

In trading on Monday, materials shares fell 1.5%.

Top Headline

Cardinal Health, Inc. CAH reported stronger-than-expected results for its third quarter on Monday.

Cardinal Health posted Q3 adjusted earnings of $1.62 per share, beating analysts’ estimates of $1.43 per share. The company’s sales came in at $39.20 billion, exceeding the consensus view of $36.95 billion.


Equities Trading UP

Cellect Biotechnology Ltd. APOP shares shot up 74% to $4.13 after the company highlighted the publication of an article in the Bone Marrow Transplantation journal. The company noted it has initiated a study in adults undergoing stem cell transplant.

Shares of MyoKardia, Inc. MYOK got a boost, shooting 64% to $100.01 after the company announced the primary and secondary endpoints for its Phase 3 EXPLORER clinical trials of Mavacamten were met.

Amneal Pharmaceuticals, Inc. AMRX shares were also up, gaining 28% to $4.548 after the company reported upbeat Q1 results and reaffirmed FY20 guidance.


Equities Trading DOWN

Recro Pharma, Inc. REPH shares tumbled 40% to $5.05 after the company reported worse-than-expected Q1 results.

Shares of ArcelorMittal MT were down 18% to $9.40 after the company reported a proposed common stock and mandatorily convertible subordinated notes offerings for $2 billion in total.

Scorpio Bulkers Inc. SALT was down, falling 15% to $17.10 after the company reported Q1 results.

Commodities


In commodity news, oil traded down 2.3% to $24.17, while gold traded down 1% to $1,697.60.

Silver traded down 0.8% Monday to $15.65, while copper fell 1.1% to $2.381.

Euro zone

European shares closed lower today. The eurozone’s STOXX 600 slipped 0.4%, the Spanish Ibex Index fell 1.63%, while Italy’s FTSE MIB Index fell 0.33%. Meanwhile, the German DAX dropped 0.73%, and the French CAC 40 fell 1.31% while UK shares rose 0.06%.


Economics

On the economics calendar Monday, there is no important data due out.

Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsPenny StocksEurozoneCommoditiesGlobalIntraday UpdateMarketsMid-Afternoon Market Update
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...